RNPC3 and systemic lupus erythematosus: In the case of SLE, around 5% of patients are affected by PAH, with the presence of anti-RNP and anti-SSA/Ro antibodies, as well as Raynaud’s phenomenon, serving as independent predictive indicators for SLE-associated PAH (10, 11).